The emerging role of artificial intelligence in neuropathology: Where are we and where do we want to go?

Journal: Pathology, research and practice
Published Date:

Abstract

The field of neuropathology, a subspecialty of pathology which studies the diseases affecting the nervous system, is experiencing significant changes due to advancements in artificial intelligence (AI). Traditionally reliant on histological methods and clinical correlations, neuropathology is now experiencing a revolution due to the development of AI technologies like machine learning (ML) and deep learning (DL). These technologies enhance diagnostic accuracy, optimize workflows, and enable personalized treatment strategies. AI algorithms excel at analyzing histopathological images, often revealing subtle morphological changes missed by conventional methods. For example, deep learning models applied to digital pathology can effectively differentiate tumor grades and detect rare pathologies, leading to earlier and more precise diagnoses. Progress in neuroimaging is another helpful tool of AI, as enhanced analysis of MRI and CT scans supports early detection of neurodegenerative diseases. By identifying biomarkers and progression patterns, AI aids in timely therapeutic interventions, potentially slowing disease progression. In molecular pathology, AI's ability to analyze complex genomic data helps uncover the genetic and molecular basis of neuropathological conditions, facilitating personalized treatment plans. AI-driven automation streamlines routine diagnostic tasks, allowing pathologists to focus on complex cases, especially in settings with limited resources. This review explores AI's integration into neuropathology, highlighting its current applications, benefits, challenges, and future directions.

Authors

  • Giuseppe Broggi
    Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Anatomic Pathology, University of Catania, Catania 95123, Italy. Electronic address: giuseppe.broggi@gmail.com.
  • Manuel Mazzucchelli
    Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Anatomic Pathology, University of Catania, Catania 95123, Italy.
  • Serena Salzano
    Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Anatomic Pathology, University of Catania, Catania 95123, Italy.
  • Giuseppe Maria Vincenzo Barbagallo
    Department of Neurological Surgery, Policlinico "G. Rodolico-S. Marco" University Hospital, Catania 95121, Italy.
  • Francesco Certo
    Department of Neurological Surgery, Policlinico "G. Rodolico-S. Marco" University Hospital, Catania 95121, Italy.
  • Magda Zanelli
    Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, Italy. Electronic address: magda.zanelli@ausl.re.it.
  • Andrea Palicelli
    Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia 42123, Italy.
  • Maurizio Zizzo
    Surgical Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia 42123, Italy.
  • Nektarios Koufopoulos
    Second Department of Pathology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens 15772, Greece.
  • Gaetano Magro
    Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Anatomic Pathology, University of Catania, Catania 95123, Italy.
  • Rosario Caltabiano
    Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Anatomic Pathology, University of Catania, Catania 95123, Italy.